Deletion of MC4R leads to hyperinsulinemia prior to the onset of obesity [15,55] while central administration of melanocortin agonists increases the sympathetic tone [56] and decreases serum insulin levels [15] demonstrating that the melanocortin activity is necessary and sufficient for the adequate balance of insulin secretion. Here, MC4R is linked to obesity due to melanocortin 4 receptor deficiency.